Ameritas Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
8,731
-33,924
| -80% | -$826K | 0.01% | 717 |
|
|
2025
Q1 | $886K | Buy |
42,655
+2,357
| +6% | +$49K | 0.04% | 436 |
|
|
2024
Q4 | $949K | Sell |
40,298
-5,031
| -11% | -$118K | 0.03% | 429 |
|
|
2024
Q3 | $1.16M | Buy |
45,329
+2,715
| +6% | +$69.5K | 0.05% | 349 |
|
|
2024
Q2 | $1M | Buy |
42,614
+3,403
| +9% | +$79.9K | 0.04% | 411 |
|
|
2024
Q1 | $1.12M | Buy |
39,211
+10,825
| +38% | +$311K | 0.05% | 348 |
|
|
2023
Q4 | $931K | Sell |
28,386
-6,417
| -18% | -$210K | 0.05% | 302 |
|
|
2023
Q3 | $963K | Buy |
+34,803
| New | +$963K | 0.05% | 350 |
|
|
2023
Q2 | – | Sell |
-48,839
| Closed | -$1.47M | – | 656 |
|
|
2023
Q1 | $1.47M | Buy |
48,839
+6,454
| +15% | +$194K | 0.07% | 247 |
|
|
2022
Q4 | $1.2M | Sell |
42,385
-8,411
| -17% | -$237K | 0.06% | 308 |
|
|
2022
Q3 | $1.67M | Sell |
50,796
-5,046
| -9% | -$166K | 0.1% | 199 |
|
|
2022
Q2 | $1.76M | Buy |
55,842
+1,489
| +3% | +$46.9K | 0.1% | 199 |
|
|
2022
Q1 | $2.5M | Buy |
54,353
+6,507
| +14% | +$299K | 0.09% | 181 |
|
|
2021
Q4 | $2.93M | Buy |
+47,846
| New | +$2.93M | 0.11% | 160 |
|